Jul 6, 2024, 13:29
ESMO – immune cell-related biomarkers in metastatic HNSCC
ESMO shared on LinkedIn:
“Latest podcast. Annals of Oncology Editor in Chief Tom Powles talks to Amanda Psyrri. They discuss her recently published study that aimed to investigate the association of immune cell-related biomarkers in the tumor and tumor microenvironment with PD-1 checkpoint inhibitors’ outcomes in patients with metastatic head and neck squamous cell cancer (HNSCC).”
Read further.
Source: ESMO/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 06:49
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12